Last reviewed · How we verify

NCT04592757

Immersive Care - Virtual Mirror Therapy

Completed NA Last updated 2 June 2021
What this trial tests

NA trial testing Virtual mirror therapy via VR headset in Stroke in 9 participants. Completed in 28 May 2021.

Timeline
14 December 2020
Primary endpoint
28 May 2021
28 May 2021

Quick facts

Lead sponsorThomas More University of Applied Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposeother
Enrollment9
Start date14 December 2020
Primary completion28 May 2021
Estimated completion28 May 2021
Sites2 locations across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Thomas More University of Applied Sciences

Who can join

Adults 18 to 85, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this implementation study is - primarily - to investigate the feasibility, acceptability, tolerability of a new virtual reality application in stroke patients, and -secondarily - to gain initial insights in the preliminary clinical effects of this application.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Thomas More University of Applied Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04592757.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing